Table 1.
The Clinicopathological Features of Patients with Endometrial Cancer
| Clinicopathological Features | Total (n = 563) |
|---|---|
| Age (years) | |
| <55, n (%) | 223(39.6%) |
| ≥55, n (%) | 340(60.4%) |
| Reproductive history | |
| No, n (%) | 16(2.8%) |
| Yes, n (%) | 547(97.2%) |
| Menopause | |
| No, n (%) | 174(30.9%) |
| Yes, n (%) | 385(68.4%) |
| Unknown, n (%) | 4(0.7%) |
| Histological type | |
| Endometrioid carcinoma, n (%) | 483(85.8%) |
| Serous carcinoma, n (%) | 33(5.9%) |
| Clear cell carcinoma, n (%) | 11(2.0%) |
| Squamous cell carcinoma, n (%) | 2(0.4%) |
| Mixed carcinoma, n (%) | 12(2.1%) |
| Others, n (%) | 7(1.2%) |
| Unknown, n (%) | 15(2.7%) |
| Tumor differentiation | |
| Well, n (%) | 118(21.0%) |
| Moderate, n (%) | 313(55.6%) |
| Poor, n (%) | 79(14.0%) |
| Unknown, n (%) | 53(9.4%) |
| Muscular infiltration | |
| Endometrium, n (%) | 84(14.9%) |
| <1/2 muscular layer, n (%) | 312(55.4%) |
| ≥1/2 muscular layer, n (%) | 92(16.3%) |
| Unknown, n (%) | 75(13.3%) |
| Lymphovascular invasion | |
| Absent, n (%) | 405(71.9%) |
| Present, n (%) | 74(13.1%) |
| Unknown, n (%) | 84(14.9%) |
| Perineural invasion | |
| Absent, n (%) | 469(83.3%) |
| Present, n (%) | 3(0.5%) |
| Unknown, n (%) | 91(16.2%) |
| Disease stage | |
| I, n (%) | 417(74.1%) |
| II, n (%) | 27(4.8%) |
| III, n (%) | 69(12.3%) |
| IV, n (%) | 20(3.6%) |
| Unknown, n (%) | 30(5.3%) |
| Molecular subtypes | |
| dMMR | 197(35.0%) |
| p53 abnormal | 155(27.5%) |
| POLE mutant | 52(9.2%) |
| NSMP | 159(28.2%) |